John W Smither Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John W Smither.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John W Smither. John W Smither is a Director in Achaogen Inc ($AKAO) and a Chief Financial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and a Director in Principia Biopharma Inc. ($PRNB) and a Chief Financial Officer in Sienna Biopharmaceuticals, Inc. ($SNNA) and a Chief Financial Officer in Arcutis Biotherapeutics, Inc. ($ARQT).
Address: C/O KYTHERA BIOPHARMACEUTICALS, INC. 27200 WEST AGOURA ROAD, SUITE 200 CALABASAS 91301 CA
Companies in which John W Smither is an Insider
Achaogen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 07 2018
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcutis Biotherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Chief Financial Officer
Holdings: 25,948 shares
Latest Transaction: Feb 12 2021
Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions
Last 3 Months Overview:
Buy: 8x
Sell: 12x
Shares Bought: 28,875
Shares Sold: 18,250
Share Difference: +10,625
Value Difference: +$554,608
KYTHERA BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Oct 02 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Principia Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Director
Holdings: 0 shares
Latest Transaction: Feb 21 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sienna Biopharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jul 17 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John W Smither
Sentiment: All, AKAO, ARQT, KYTH, PRNB, SNNA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 750 | 1,260 | 45,482 | |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 2,000 | 71,280 | 87,965 | 90 K to 88 K (-2.22 %) |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 750 | 26,730 | 25,198 | 25.9 K to 25.2 K (-2.89 %) |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 750 | 1,260 | 25,948 | 25.2 K to 25.9 K (+2.98 %) |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,250 | 2,101 | 46,232 | |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 3,750 | 131,250 | 89,965 | 93.7 K to 90 K (-4.00 %) |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 1,250 | 43,750 | 25,198 | 26.4 K to 25.2 K (-4.73 %) |